IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v526y2015i7572d10.1038_nature14969.html
   My bibliography  Save this article

The genomic landscape of response to EGFR blockade in colorectal cancer

Author

Listed:
  • Andrea Bertotti

    (University of Turin Medical School
    Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS
    National Institute of Biostructures and Biosystems (INBB))

  • Eniko Papp

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Siân Jones

    (Personal Genome Diagnostics)

  • Vilmos Adleff

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Valsamo Anagnostou

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Barbara Lupo

    (University of Turin Medical School
    Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Mark Sausen

    (Personal Genome Diagnostics)

  • Jillian Phallen

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Carolyn A. Hruban

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Collin Tokheim

    (Institute for Computational Medicine, Johns Hopkins University)

  • Noushin Niknafs

    (Institute for Computational Medicine, Johns Hopkins University)

  • Monica Nesselbush

    (Personal Genome Diagnostics)

  • Karli Lytle

    (Personal Genome Diagnostics)

  • Francesco Sassi

    (Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Francesca Cottino

    (Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Giorgia Migliardi

    (University of Turin Medical School
    Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Eugenia R. Zanella

    (University of Turin Medical School
    Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Dario Ribero

    (Mauriziano Umberto I Hospital
    †Present address: European Institute of Oncology (IEO), 20141 Milan, Italy)

  • Nadia Russolillo

    (Mauriziano Umberto I Hospital)

  • Alfredo Mellano

    (Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Andrea Muratore

    (Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Gianluca Paraluppi

    (Liver Transplantation Center, San Giovanni Battista Hospital)

  • Mauro Salizzoni

    (Liver Transplantation Center, San Giovanni Battista Hospital
    University of Turin Medical School)

  • Silvia Marsoni

    (Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Michael Kragh

    (Symphogen A/S)

  • Johan Lantto

    (Symphogen A/S)

  • Andrea Cassingena

    (Niguarda Cancer Center, Ospedale Niguarda Ca’ Granda)

  • Qing Kay Li

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Rachel Karchin

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
    Institute for Computational Medicine, Johns Hopkins University)

  • Robert Scharpf

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

  • Andrea Sartore-Bianchi

    (Niguarda Cancer Center, Ospedale Niguarda Ca’ Granda)

  • Salvatore Siena

    (Niguarda Cancer Center, Ospedale Niguarda Ca’ Granda
    University of Milan Medical School)

  • Luis A. Diaz

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
    Swim Across America Laboratory, The Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins)

  • Livio Trusolino

    (University of Turin Medical School
    Translational Cancer Medicine, Surgical Oncology, and Clinical Trials Coordination, Candiolo Cancer Institute – Fondazione del Piemonte per l’Oncologia IRCCS)

  • Victor E. Velculescu

    (Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine)

Abstract

The effect of somatic genetic changes in colorectal cancer on sensitivity to anti-EGFR antibody therapy is analysed.

Suggested Citation

  • Andrea Bertotti & Eniko Papp & Siân Jones & Vilmos Adleff & Valsamo Anagnostou & Barbara Lupo & Mark Sausen & Jillian Phallen & Carolyn A. Hruban & Collin Tokheim & Noushin Niknafs & Monica Nesselbush, 2015. "The genomic landscape of response to EGFR blockade in colorectal cancer," Nature, Nature, vol. 526(7572), pages 263-267, October.
    • Handle: RePEc:nat:nature:v:526:y:2015:i:7572:d:10.1038_nature14969
    DOI: 10.1038/nature14969
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature14969
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature14969?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yan Li & Bing Wang & Wentao Yang & Fahan Ma & Jianling Zou & Kai Li & Subei Tan & Jinwen Feng & Yunzhi Wang & Zhaoyu Qin & Zhiyu Chen & Chen Ding, 2024. "Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
    2. Radia M. Johnson & Xueping Qu & Chu-Fang Lin & Ling-Yuh Huw & Avinashnarayan Venkatanarayan & Ethan Sokol & Fang-Shu Ou & Nnamdi Ihuegbu & Oliver A. Zill & Omar Kabbarah & Lisa Wang & Richard Bourgon , 2022. "ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer," Nature Communications, Nature, vol. 13(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:526:y:2015:i:7572:d:10.1038_nature14969. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.